Disease-associated GARS mutations are involved in neurotoxicity in Charcot–Marie–Tooth disease (CMT) [12] and GARS was reported to be associated with the occurrence and development of various cancers [13,14,15]. This evidence concerns the gene GARS1 and Charcot-Marie-Tooth disease.